Animal Vaccines Market- Global Market Analysis & Outlook Report, 2019-2025 -

Global Animal Vaccines Market Report provides a complete decision-making overview including definition, product specifications, market gains, key geographic regions and imminent Industrial Safety Gloves peers for 2019-2025.

Germany animal vaccines market will reach USD 432.6 million by 2025. Intake of animal source protein is high in Germany. With intentions to curb the spreading of zoonotic diseases, government in conjunction with companies is taking efforts in developing and introducing new vaccines, that will augment market growth during the projected timeframe.

Japan animal vaccines market will witness robust growth at 10.0% CAGR during the projected timeframe. Consumption of meat has been increasing rapidly, giving rise to growing need for animal farming in the country. Vaccination of food animals is a popular practice in Japan. Mandatory vaccination programs for poultry, swine and cattle will foster market growth in the future.

Request a sample of this premium report titled at

The Global Animal Vaccines Market To Surpass USD 9.0 billion by 2025; as per a new research report.

Technological advancement in animal vaccines include development of new vaccination methods such as nasal delivery, air-driven vaccine that penetrates through skin for cats to prevent cancer occurrence at the vaccine injection site. Growing disease burden and technological advancements will positively impact demand for animal vaccines, thereby driving industry growth during the forecast period.

Growing adoption of pets for companionship will drive animal vaccines industry growth. According to The European Pet Food Industry statistics, there were around 75 million pet owning homes in Europe in the year 2014. Moreover, increasing animal farming, growing pet adoption rate and safeguarding animal health will escalate demand for animal vaccines and augment market growth.

Farm animal vaccines market will reach USD 6,509.6 million by 2025. Farm animals have been gaining popularity, owning to rising awareness towards animal health coupled with increasing consumers demand for risk-free food. Moreover, higher demand for animal protein and increasing consumer concern over food safety will favor industry growth in the future.

Toxoid vaccines market will show significant growth of 4.8% CAGR during the projected timeframe, owing to high adoption rate. Increasing adoption rate is attributable to various technological advances that enhance efficacy and safety of toxoid vaccines. Large number of advantages associated with toxoid vaccines is major factor for segmental growth in the future.

Viral vaccines industry accounted for largest market value of USD 3,792.4 million in 2018. Growth is attributed to increasing number of viral infections that significantly hamper animal farming. Growing prevalence of viral infections such as Newcastle’s disease and influenza will render positive impact on business growth during the forecast timeframe.

Injection vaccines business will grow at 4.3% CAGR across the forecast timeframe. High growth is due to various advantages associated with injection vaccines such as improved and quick onset of immunity. Increasing pervasiveness of zoonotic diseases will significantly impact business growth during the forecast timeframe.

Prominent industries involved in animal vaccines market are Boehringer Ingelheim Animal Health, Ceva Sante Animale, Dechra Pharmaceuticals, Durvet, Inc, Elanco, Henry Schein Animal Health, Hipra Animal Health Limited, Merck Animal Health, Neogen Corporation and Zoetis. These prominent business players are focusing on strategic mergers, acquisitions and new product launch to strengthen market position. For instance, in June 2016, Ceva Sante Animale acquired Biovac, manufacturer of autogenous vaccines. The acquisition will help Ceva to expand its vaccine portfolio which in turn will help in generating more revenue.

Request a discount on standard prices of this premium report titled at

Table Of Content:

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary Paid sources Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Animal vaccines industry 360 degree synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Animal type trends

2.1.3. Technology trends

2.1.4. Infections trends

2.1.5. Route of administration trends

2.1.6. Regional trends

Chapter 3. Animal Vaccines Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025

3.3. Industry impact forces

3.3.1. Growth drivers Growing trend of adopting pet animals Rising prevalence of food borne and zoonotic diseases Favorable government initiatives Rapidly increasing demand for animal protein in human food Technological advancement in development of animal health vaccines

3.3.2. Industry pitfalls & challenges Lack of infrastructure in developing nations for vaccine development Low out of pocket expenditure on pet healthcare in developing countries

3.4. Growth potential analysis

3.4.1. By animal type

3.4.2. By technology

3.4.3. By infections

3.4.4. By route of administration

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.5.3. Asia-Pacific

3.6. Public and private institutional initiatives

3.6.1. U.S.

3.6.2. Europe

3.6.3. Asia-Pacific

3.7. Technology landscape

3.8. Pipeline analysis

3.9. Porter's analysis

3.10. Competitive landscape, 2017

3.10.1. Strategy dashboard

3.11. PESTEL analysis

Chapter 4. Animal Vaccines Market, By Animal Type

4.1. Key segment trends

4.2. Farm animals

4.2.1. Market size, by region, 2014 - 2025 (USD Million)

4.2.2. Poultry vaccines Market size, by region, 2014 - 2025 (USD Million)

4.2.3. Cattle vaccines Market size, by region, 2014 - 2025 (USD Million)

4.2.4. Swine vaccines Market size, by region, 2014 - 2025 (USD Million)

4.2.5. Equine vaccines Market size, by region, 2014 - 2025 (USD Million)

4.2.6. Aquaculture vaccines Market size, by region, 2014 - 2025 (USD Million)

4.3. Companion animals

4.3.1. Market size, by region, 2014 - 2025 (USD Million)

4.3.2. Dog vaccines Market size, by region, 2014 - 2025 (USD Million)

4.3.3. Cat vaccines Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Animal Vaccines Market, By Technology

5.1. Key segment trends

5.2. Live attenuated vaccines

5.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.3. Inactivated vaccines

5.3.1. Market size, by region, 2014 - 2025 (USD Million)

5.4. Toxoid vaccines

5.4.1. Market size, by region, 2014 - 2025 (USD Million)

5.5. Recombinant vaccines

5.5.1. Market size, by region, 2014 - 2025 (USD Million)

5.6. Others

5.6.1. Market size, by region, 2014 - 2025 (USD Million)


More Details on this Report At:

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910

Release ID: 88911237